Genetic variability of HIF1A and response to treatment with cisplatin in combination with pemetrexed or gemcitabine in patients with malignant mesothelioma

Published Online: Sep 05, 2025

Page range: 403 - 411

Received: Jun 15, 2025

Accepted: Jul 19, 2025

DOI: https://doi.org/10.2478/raon-2025-0049

Keywords

malignant mesothelioma, chemotherapy, hypoxia-inducible factor, polymorphism

© 2025 Matic Setina et al., published by Sciendo

This work is licensed under the Creative Commons Attribution 4.0 International License.